Financial News
Cellectar Biosciences, Inc. - Common Stock (NQ:CLRB)
Price and Volume
Detailed Quote| Volume | 479 |
| Open | 3.810 |
| Bid (Size) | 3.810 (100) |
| Ask (Size) | 3.930 (100) |
| Prev. Close | 3.810 |
| Today's Range | 3.810 - 3.810 |
| 52wk Range | 2.450 - 20.59 |
| Shares Outstanding | 3,192,040 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
Earnings Scheduled For August 14, 2025 ↗
August 14, 2025
A Peek at Cellectar Biosciences's Future Earnings ↗
August 13, 2025
Earnings Outlook For Cellectar Biosciences ↗
November 12, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
October 07, 2025
Cellectar Cuts Q2 Losses and Expenses ↗
August 14, 2025
Frequently Asked Questions
Is Cellectar Biosciences, Inc. - Common Stock publicly traded?
Yes, Cellectar Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Cellectar Biosciences, Inc. - Common Stock trade on?
Cellectar Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cellectar Biosciences, Inc. - Common Stock?
The ticker symbol for Cellectar Biosciences, Inc. - Common Stock is CLRB on the Nasdaq Stock Market
What is the current price of Cellectar Biosciences, Inc. - Common Stock?
The current price of Cellectar Biosciences, Inc. - Common Stock is 3.810
When was Cellectar Biosciences, Inc. - Common Stock last traded?
The last trade of Cellectar Biosciences, Inc. - Common Stock was at 01/22/26 04:00 PM ET
What is the market capitalization of Cellectar Biosciences, Inc. - Common Stock?
The market capitalization of Cellectar Biosciences, Inc. - Common Stock is 12.16M
How many shares of Cellectar Biosciences, Inc. - Common Stock are outstanding?
Cellectar Biosciences, Inc. - Common Stock has 12M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
